Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06925295Phase 2Recruiting
Phase 2, open-label trial in lung cancer (2 arms). Primary endpoints: Incidence of PFT evidence of radiation pneumonitis at 6 months and Lung function change on spirometry at 6 months. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06925295.